Skip to main content

Table 5 ANOVA results of main pharmacokinetic parameters in the fed group

From: Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study

Dependent variable Subject Treatment Period Preparation
F a P b F P F P F P
LnCmax 6.49 0.0000 0.01 0.9110 1.22 0.2819 1.08 0.3101
LnAUC0–t 13.50 0.0000 0.11 0.7425 4.91 0.0373 0.01 0.9302
LnAUC0–∞ 15.68 0.0000 0.04 0.8485 3.51 0.0745 0.01 0.9404
  1. aF = Fisher value
  2. bP = probability value